Oncology

o25

AMSTERDAM CRITERIA

the traditional requirements for recognizing a family with genetic nonpolyposis colorectal cancer. The requirements are marked by a three-two-one prototype:

ANTIANDROGEN THERAPY

a type of medical treatment using anitandrogens to mitigate an excessive level of male hormones. Specifically, it may correct hair

ANTIESTROGEN

a substance (e.g., tamoxifen) that lessens the physiological effects of estrogenic hormones on the tissues that are normally responsive to

ATTRIBUTABLE RISK

in epidemiology, the incidence rate of a disease or disorder that can be considered to have been caused by exposure

BCL-2

n. a family of regulator proteins, first of which is the B-Cell Lymphoma-2 (BCL-2) gene. These are genes whose proteins

BRCA1 AND BRCA2

n. the first-two major cancer genes associated with a person's susceptibility to breast and ovarian cancer. In women with mutations

CANCER

n. a group of pathological conditions characterized by the abnormal growth of cells. Locally, this abnormal mass may develop into

CANCER PHOBIA

n. an irrational fear of cancer which pervades one's thoughts. The fear of developing cancer becomes all-consuming, and this is